Targeted Oncology11d
Velcheti Evaluates Activity of Repotrectinib for ROS1 Fusion–Positive NSCLC
During a Case-Based Roundtable® event, Vamsidhar Velcheti, MD, discussed the TRIDENT-1 trial and practical considerations for ...
Scoop14d
Pharmac Funding Decision Will Increase Medicines Access
Associate Health Minister with responsibility for Pharmac David Seymour, and Health Minister Simeon Brown welcome Pharmac’s decision to fund medicines for a further five health conditions, including ...
Armed robbery in Revesby14d
Pharmac Funding Boost Expands Medicines Access 12 March
Associate Health Minister with responsibility for Pharmac David Seymour, and Health Minister Simeon Brown welcome Pharmac's decision to fund medicines for a further five health conditions, including ...
Memorial Sloan Kettering Cancer Center16d
How One Young Adult With Stage 4 Lung Cancer Is Beating the Odds
Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo Oviedo-Mori survive — and thrive — with advanced lung cancer for 15 years.
ascopubs.org27d
Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3
Reply to: Treatment Intensification Based on Residual Disease in Elderly Patients With AML ...